← Evidence map

ReviewMycoses2018

Isavuconazole treatment for rare fungal diseases and for invasive aspergillosis in patients with renal impairment: Challenges and lessons of the VITAL trial.

John R Perfect et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

15 papers cite it

2018
2019
2020
2021
2022
2023
2024
2025
2026
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 29570857